frictionless movement and sustains large compressive forces between long bones. It is molecularly, morphologically and histologically distinct from transient cartilage, the embryonic cartilage that is eventually replaced by bone. Ray et al., in their recent study, have proposed a model for concomitant differentiation of articular cartilage and transient cartilage from a common pool of proliferative progenitors involving an interplay between Wnt and BMP signalling pathways. This study and others have demonstrated that Wnt signalling is sufficient in inducing articular cartilage differentiation. Despite the indispensable role of Wnt signalling during articular cartilage development, its downstream target genes still remain unknown in this context. Present study aims at identifying the downstream target genes of Wnt signalling pathway during articular cartilage differentiation. Here, we have designed and developed an in-vitro system of articular cartilage differentiation based on the model proposed by Ray et al and conducted a microarray based expression screen to identify novel downstream target genes of Wnt signalling during articular cartilage differentiation. The novel candidate genes identified in this screen are being investigated for Wnt signalling dependent in situ mRNA expression analysis. The genes thus identified will be functionally tested for their ability to support articular cartilage differentiation in vivo. This study, once completed, may offer novel drug targets for osteoarthritis. Lymphedema is the consequence of inefficient uptake and/or reduced lymph flow, which leads to the accumulation of highprotein fluid beneath the skin and chronic swelling of extremities. Twenty genes belonging to the VEGFR3 pathway have been identified as causing lymphedema when mutated in humans.
Here, we report three individuals diagnosed with a new recessive syndrome presenting with progressive lymphedema and sensorineural hearing loss (SNHL). Whole-exome sequencing identified causative mutations, including a protein-null allele, in CPD which encodes for Carboxypeptidase D.
CPD is a circulating protease which hydrolyses proteins with a lysine or arginine at their C-terminus. To date, no endogenous substrates for CPD have been identified. Using patient-derived primary cells and zebrafish knockout animals, we aim to understand the pathogenesis of this new disease to develop CPD as a potential therapeutic for the treatment of lymphedema. Craniosynostosis is a common craniofacial birth defect, and is characterised by the premature fusion of cranial sutures in the developing calvarium. Activating mutations in the FGFR2 gene is one of the causes for craniosynostosis and is associated with pathogenic FGFR2 signalling. In particular, mutations in the IIIc isoform (e.g. FGFR2c-C342Y) contribute to coronal synostosis, a common phenotype in human Crouzon Syndrome. However, the mechanisms responsible for coronal suture patency remain poorly defined: this study aims to uncover the downstream effects of pathogenic FGFR2c signalling for craniosynostosis in vivo. Previously identified Fgfr2c target readouts (Spry2, Spry4, Etv5) were interrogated using in situ hybridisation in the coronal sutures of a mouse model for craniosynostosis (Fgfr2cC342Y/+). Interestingly, no ectopic signalling activity was detected compared to the Wild-Type (WT). Subsequently, RNAseq transcriptomic analysis of coronal sutures acquired using Laser Captured Microdissection was performed on Fgfr2cC342Y/+ and WTs at E16.5, prior to suture closure. Differential expression analysis of the dataset identifies 86 genes upregulated and 325 genes downregulated more than 10-fold in mutant sutures. Furthermore, Gene Set Enrichment Analysis demonstrates decreased pAKT signalling enrichment in Fgfr2cC342Y/+ coronal sutures. Separately, overexpression of Fgfr2c in a novel transgenic mouse model (R26RFgfr2cV5/Fgfr2cV5) did not yield craniosynostosis but instead, exhibited skeletal hypoplasia in Neural Crest derived craniofacial structures and cleft palate. Together, these results support the hypothesis that craniosynostosis involves attenuated levels of downstream FGF signalling. Ongoing work includes elucidating the nature of FGFR2c signalling pathway at the protein level, and the introduction of Fgfr2c overexpressing allele into the Fgfr2cC342Y/+ mice in an attempt to prevent coronal synostosis. Elucidating the complex nature of FGFR2c signalling will improve the understanding of normal craniofacial development and its related pathologies, while providing a framework for the development of novel therapeutic strategies. Integrated clinical and genetic analyses frequently facilitate insight into a range of pediatric disease. Characterization of an ocular developmental disorder, that is associated with cerebellar anomalies and mid-facial hypoplasia, led us to test if the causal transcription factor impacted ciliary function. Manipulating its dosage in murine fibroblasts by shRNA inhibition (n =4) and overexpression (pLXSH) resulted in significant alterations to axonemal length, and to the three cilia-mediated signalling pathways assayed [Hedgehog, PDGF and TGF-beta]. Consistently, mRNA over-expression in zebrafish embryos induced cilia lengthening; and at later stages (24 and 48 hpf) cardiac left-right patterning defects. RNAsequencing demonstrated dysregulated expression of Tctn2, a component of the ciliary Transition Zone, findings supported by qPCR in two cell lines and ChIP-Seq data. Such results, plus patient phenotypes characteristic of impaired Hedgehog signalling, encouraged us to test whether paralogs exhibited similar effects. shRNA inhibition of fifteen members of the gene family significantly altered cilia length in nine cases. Intrigued by the six that did not exhibit structural effects, despite in some cases extensive interactions with Hedgehog signaling, we hypothesized that they might regulate cilia function without affecting cilia structure. We selected one such paralog for detailed study and induced a substantial reduction in Gli1 when it was inhibited with multiple shRNAs. Taken together, these findings demonstrate that these genes modulate cilia-mediated signalling, with a potential contribution to this gene family's wellrecognized roles in organ development and disease. Hepatocellular carcinoma (HCC) now is the sixth leading cancer worldwide and causes millions of death annually. HCC shows gender disparity during carcinogenesis, which means that men have significantly higher incidence and mortality rate of HCC than women. HCC seldom shows regression among patients, and whether the gender disparity shown in HCC regression now is unclear due to low frequency of the HCC regression and the few research on this phenomenon. In our lab, the transgenic zebrafish with xmrk and c-myc expression in liver showed rapid development of HCC during induction and rapid regression after withdrawal of the inducer, which makes it an appropriate tool for investigating the HCC regression. Sex hormones are believed to play an important role in gender disparity of HCC progression. In present study, the xmrk/myc adult fish with well-progressed HCC were recovering, along with different sex hormone treatments. After treatments, it showed that the HCC regression were accelerated by exogenous estrogen and slowed down by androgen treatment. Overall, our study presented that HCC regression showed significant gender disparity, and sex hormones affect regression of HCC, which may provide a new idea about HCC therapy. 
